ATE534391T1 - 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen - Google Patents
3,11b-cis-dihydrotetrabenazin zur behandlung von psychosenInfo
- Publication number
- ATE534391T1 ATE534391T1 AT08170385T AT08170385T ATE534391T1 AT E534391 T1 ATE534391 T1 AT E534391T1 AT 08170385 T AT08170385 T AT 08170385T AT 08170385 T AT08170385 T AT 08170385T AT E534391 T1 ATE534391 T1 AT E534391T1
- Authority
- AT
- Austria
- Prior art keywords
- dihydrotetrabenazine
- psychoses
- cis
- treatment
- schizophrenia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0516167.4A GB0516167D0 (en) | 2005-08-06 | 2005-08-06 | Pharmaceutical compounds |
| GB0516790A GB0516790D0 (en) | 2005-08-16 | 2005-08-16 | Pharmaceutical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE534391T1 true ATE534391T1 (de) | 2011-12-15 |
Family
ID=37400949
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06765238T ATE415968T1 (de) | 2005-08-06 | 2006-08-04 | 3,11b-cis-dihydrotetrabanezin zur behandlung von schizophrenie und anderen psychosen |
| AT08170385T ATE534391T1 (de) | 2005-08-06 | 2006-08-04 | 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06765238T ATE415968T1 (de) | 2005-08-06 | 2006-08-04 | 3,11b-cis-dihydrotetrabanezin zur behandlung von schizophrenie und anderen psychosen |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20110257220A1 (de) |
| EP (2) | EP2050451B1 (de) |
| JP (1) | JP2009504622A (de) |
| KR (1) | KR20080033500A (de) |
| AT (2) | ATE415968T1 (de) |
| AU (1) | AU2006277753B2 (de) |
| CA (1) | CA2620960A1 (de) |
| CY (1) | CY1108843T1 (de) |
| DE (1) | DE602006004009D1 (de) |
| DK (1) | DK1855677T3 (de) |
| ES (1) | ES2318771T3 (de) |
| HK (1) | HK1111083A1 (de) |
| HR (1) | HRP20090074T3 (de) |
| MX (1) | MX2008001549A (de) |
| NZ (1) | NZ566011A (de) |
| PL (1) | PL1855677T3 (de) |
| PT (1) | PT1855677E (de) |
| RS (1) | RS50807B (de) |
| RU (1) | RU2407743C2 (de) |
| SI (1) | SI1855677T1 (de) |
| WO (1) | WO2007017654A1 (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8039627B2 (en) | 2006-11-08 | 2011-10-18 | Neurocrine Biosciences, Inc. | Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-A]isoquinolin-2-ol compounds and methods relating thereto |
| US7897768B2 (en) | 2007-06-08 | 2011-03-01 | General Electric Company | Method for making tetrabenazine compounds |
| US8053578B2 (en) | 2007-11-29 | 2011-11-08 | General Electric Company | Alpha-fluoroalkyl dihydrotetrabenazine imaging agents and probes |
| GB0810857D0 (en) * | 2008-06-13 | 2008-07-23 | Cambridge Lab Ireland Ltd | Pharmaceutical compounds |
| GB2463283A (en) * | 2008-09-08 | 2010-03-10 | Cambridge Lab | 3,11b-cis-dihydrotetrabenazine for use in treating asthma |
| GB2463451A (en) * | 2008-09-08 | 2010-03-17 | Cambridge Lab | 3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia |
| AU2011261551B2 (en) | 2010-06-01 | 2016-10-20 | Auspex Pharmaceutical, Inc. | Benzoquinolone inhibitors of VMAT2 |
| WO2012135595A2 (en) | 2011-04-01 | 2012-10-04 | 3M Innovative Properties Company | Films including triazine-based ultraviolet absorbers |
| WO2015112707A1 (en) | 2014-01-27 | 2015-07-30 | Auspex Pharmaceuticals, Inc. | Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| EP3102239A1 (de) * | 2014-02-07 | 2016-12-14 | Neurocrine Biosciences, Inc. | Pharmazeutische zusammensetzungen mit antipsychotika und vmat2-inhibitor sowie verwendungen davon |
| NZ742006A (en) | 2015-10-30 | 2024-10-25 | Neurocrine Biosciences Inc | Valbenazine salts and polymorphs thereof |
| US10160757B2 (en) | 2015-12-23 | 2018-12-25 | Neuroscrine Biosciences, Inc. | Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) |
| EP3548027A1 (de) * | 2016-12-02 | 2019-10-09 | Neurocrine Biosciences, Inc. | Verwendung von valbenazin zur behandlung von schizophrenie oder schizoaffektiver störung |
| KR20250022883A (ko) | 2017-01-27 | 2025-02-17 | 뉴로크린 바이오사이언시즈 인코퍼레이티드 | 특정 vmat2 억제제의 투여 방법 |
| GB201705304D0 (en) | 2017-04-01 | 2017-05-17 | Adeptio Pharmaceuticals Ltd | Pharmaceutical compositions |
| GB201705302D0 (en) | 2017-04-01 | 2017-05-17 | Adeptio Pharmaceuticals Ltd | Pharmaceutical compositions |
| GB201705306D0 (en) | 2017-04-01 | 2017-05-17 | Adeptio Pharmaceuticals Ltd | Pharmaceutical compositions |
| GB201705303D0 (en) | 2017-04-01 | 2017-05-17 | Adeptio Pharmaceuticals Ltd | Pharmaceutical compositions |
| IL309802A (en) | 2017-09-21 | 2024-02-01 | Neurocrine Biosciences Inc | High dosage valbenazine formulation and compositions, methods, and kits related thereto |
| AU2017435893B2 (en) | 2017-10-10 | 2023-06-29 | Neurocrine Biosciences, Inc | Methods for the administration of certain VMAT2 inhibitors |
| US10993941B2 (en) | 2017-10-10 | 2021-05-04 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
| GB201808464D0 (en) | 2018-05-23 | 2018-07-11 | Adeptio Pharmaceuticals Ltd | Pharmaceutical compounds for use in treating huntington's disease |
| TW202021585A (zh) | 2018-08-15 | 2020-06-16 | 美商紐羅克里生物科學有限公司 | 用於特定vmat2抑制劑之投與之方法 |
| US10940141B1 (en) | 2019-08-23 | 2021-03-09 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2843591A (en) | 1958-07-15 | Method for preparing same | ||
| US2830993A (en) | 1958-04-15 | Quinolizine derivatives | ||
| US6087376A (en) * | 1997-02-05 | 2000-07-11 | University Of Kentucky Research Foundation | Use of lobeline compounds in the treatment of central nervous system diseases and pathologies |
| GB2410947B (en) * | 2004-02-11 | 2008-09-17 | Cambridge Lab Ltd | Pharmaceutical compounds |
-
2006
- 2006-08-04 ES ES06765238T patent/ES2318771T3/es active Active
- 2006-08-04 CA CA002620960A patent/CA2620960A1/en not_active Abandoned
- 2006-08-04 EP EP08170385A patent/EP2050451B1/de active Active
- 2006-08-04 DK DK06765238T patent/DK1855677T3/da active
- 2006-08-04 US US11/997,591 patent/US20110257220A1/en not_active Abandoned
- 2006-08-04 RU RU2008108623/04A patent/RU2407743C2/ru not_active IP Right Cessation
- 2006-08-04 NZ NZ566011A patent/NZ566011A/en not_active IP Right Cessation
- 2006-08-04 WO PCT/GB2006/002936 patent/WO2007017654A1/en active Application Filing
- 2006-08-04 AT AT06765238T patent/ATE415968T1/de active
- 2006-08-04 EP EP06765238A patent/EP1855677B1/de active Active
- 2006-08-04 DE DE602006004009T patent/DE602006004009D1/de active Active
- 2006-08-04 PL PL06765238T patent/PL1855677T3/pl unknown
- 2006-08-04 RS RSP-2009/0055A patent/RS50807B/sr unknown
- 2006-08-04 MX MX2008001549A patent/MX2008001549A/es active IP Right Grant
- 2006-08-04 AT AT08170385T patent/ATE534391T1/de active
- 2006-08-04 AU AU2006277753A patent/AU2006277753B2/en not_active Expired - Fee Related
- 2006-08-04 JP JP2008525620A patent/JP2009504622A/ja not_active Ceased
- 2006-08-04 KR KR1020087005308A patent/KR20080033500A/ko not_active Application Discontinuation
- 2006-08-04 PT PT06765238T patent/PT1855677E/pt unknown
- 2006-08-04 SI SI200630210T patent/SI1855677T1/sl unknown
-
2008
- 2008-05-20 HK HK08105580.7A patent/HK1111083A1/xx not_active IP Right Cessation
-
2009
- 2009-02-06 HR HR20090074T patent/HRP20090074T3/xx unknown
- 2009-02-26 CY CY20091100221T patent/CY1108843T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1855677E (pt) | 2009-01-13 |
| HK1111083A1 (en) | 2008-08-01 |
| EP2050451A1 (de) | 2009-04-22 |
| DE602006004009D1 (de) | 2009-01-15 |
| CY1108843T1 (el) | 2014-07-02 |
| ATE415968T1 (de) | 2008-12-15 |
| MX2008001549A (es) | 2008-04-04 |
| JP2009504622A (ja) | 2009-02-05 |
| NZ566011A (en) | 2011-01-28 |
| US20110257220A1 (en) | 2011-10-20 |
| CA2620960A1 (en) | 2007-02-15 |
| AU2006277753A1 (en) | 2007-02-15 |
| WO2007017654A1 (en) | 2007-02-15 |
| EP1855677B1 (de) | 2008-12-03 |
| AU2006277753B2 (en) | 2011-11-10 |
| KR20080033500A (ko) | 2008-04-16 |
| SI1855677T1 (sl) | 2009-04-30 |
| HRP20090074T3 (en) | 2009-04-30 |
| EP2050451B1 (de) | 2011-11-23 |
| RU2407743C2 (ru) | 2010-12-27 |
| RS50807B (sr) | 2010-08-31 |
| ES2318771T3 (es) | 2009-05-01 |
| EP1855677A1 (de) | 2007-11-21 |
| RU2008108623A (ru) | 2009-09-20 |
| PL1855677T3 (pl) | 2009-07-31 |
| DK1855677T3 (da) | 2009-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE534391T1 (de) | 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen | |
| ATE412414T1 (de) | 3,11b-cis-dihydrotetrabenazin zur behandlung von proliferativen krankheiten oder entzündungen | |
| ATE410430T1 (de) | 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose | |
| ATE550338T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| TW200612910A (en) | Medicaments comprising carbonyl compounds, and the use thereof | |
| HK1092467A1 (en) | N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n- | |
| RS51069B (sr) | Upotreba oksikodona za tretiranje visceralnog bola | |
| ATE408601T1 (de) | Fredericamycin-derivate | |
| DK1594833T3 (da) | 1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme | |
| DE602006020871D1 (de) | Lineare harnstoffmimetika-antagonisten des p2y1-rezeptors zur behandlung von thromboseleiden | |
| DE602007005697D1 (de) | Verwendung von carrageenan zur behandlung von rhinovirus-infektionen | |
| DE60312736D1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
| DE602005019247D1 (de) | Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen | |
| DE602004003952D1 (de) | Substituierte tetrahydrobenzothienopyrimidinamine verbindungen geeignet zur behandlung von hyper-proliferative disorders | |
| DE602006003094D1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit | |
| BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
| EA200601837A1 (ru) | Бензоксазины для лечения заболеваний дыхательных путей | |
| DE602006002608D1 (de) | 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit | |
| ATE446754T1 (de) | Verbindungen zur behandlung von schizophrenie und/oder glucoregulatorische auffälligkeiten | |
| CY1110027T1 (el) | Συνδυασμος ενωσεων πυριμιδυλαμινοβενζαμιδης και ιματινιβης για τη θεραπεια ή την προληψη των νεοπλασματικων ασθενειων | |
| DE602004020337D1 (de) | Anticholinergika enthaltende Arzneimittel zur Behandlung von Krankheiten der ableitenden Harnwege | |
| ATE473737T1 (de) | Verwendung von 2,3-dehydronaringenin-derivaten zur behandlung von entzündungsprozessen und diese derivate enthaltende pharmazeutische zusammensetzung | |
| TW200744581A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder |